View Item 

Show simple item record

Graft and Patient Survival in Kidney Transplant Recipients Selected for de novo Steroid-Free Maintenance Immunosuppression
dc.contributor.authorLuan, Fu Len_US
dc.contributor.authorSteffick, Diane Een_US
dc.contributor.authorGadegbeku, Crystal Aen_US
dc.contributor.authorNorman, Silas P.en_US
dc.contributor.authorWolfe, Robert A.en_US
dc.contributor.authorOjo, Akinlolu O.en_US
dc.date.accessioned2010-06-01T20:34:53Z
dc.date.available2010-06-01T20:34:53Z
dc.date.issued2009-01en_US
dc.identifier.citationLuan, F. L.; Steffick, D. E.; Gadegbeku, C.; Norman, S. P.; Wolfe, R.; Ojo, A. O. (2009). "Graft and Patient Survival in Kidney Transplant Recipients Selected for de novo Steroid-Free Maintenance Immunosuppression." American Journal of Transplantation 9(1): 160-168. <http://hdl.handle.net/2027.42/73689>en_US
dc.identifier.issn1600-6135en_US
dc.identifier.issn1600-6143en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/73689
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=18976304&dopt=citationen_US
dc.format.extent368483 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Incen_US
dc.rights© 2009 American Society of Transplantation and the American Society of Transplant Surgeonsen_US
dc.subject.otherKidney Transplantationen_US
dc.subject.otherSteroid-free Immunosuppressive Regimensen_US
dc.subject.otherSurvival Analysisen_US
dc.titleGraft and Patient Survival in Kidney Transplant Recipients Selected for de novo Steroid-Free Maintenance Immunosuppressionen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumInternal Medicine, Division of Nephrology, University of Michigan, Ann Arbor, MIen_US
dc.contributor.affiliationotherArbor Research Collaborative for Health, Ann Arbor, MIen_US
dc.identifier.pmid18976304en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/73689/1/j.1600-6143.2008.02442.x.pdf
dc.identifier.doi10.1111/j.1600-6143.2008.02442.xen_US
dc.identifier.sourceAmerican Journal of Transplantationen_US
dc.identifier.citedreferenceHume DM, Merrill JP, Miller BF, Thorn GW. Experiences with renal homotransplantation in the human: Report of nine cases. J Clin Invest 1955; 34: 327 – 382.en_US
dc.identifier.citedreferenceMurray JE, Merrill JP, Harrison JH, Wilson RE, Dammin GJ. Prolonged survival of human-kidney homografts by immunosuppressive drug therapy. N Engl J Med 1963; 268: 1315 – 1323.en_US
dc.identifier.citedreferenceReemtsma K, McCracken BH, Schlegel JU, Pearl MA, Dewitt CW, Creech O, Jr. Reversal of early graft rejection after renal heterotransplantation in man. JAMA 1964; 187: 691 – 696.en_US
dc.identifier.citedreferenceBell PR, Briggs JD, Calman KC et al. Reversal of acute clinical and experimental organ rejection using large doses of intravenous prednisolone. Lancet 1971; 1: 876 – 880.en_US
dc.identifier.citedreferenceMiller LW. Cardiovascular toxicities of immunosuppressive agents. Am J Transplant 2002; 2: 807 – 818.en_US
dc.identifier.citedreferenceArner P, Gunnarsson R, Blomdahl S, Groth CG. Some characteristics of steroid diabetes: A study in renal-transplant recipients receiving high-dose corticosteroid therapy. Diabetes Care 1983; 6: 23 – 25.en_US
dc.identifier.citedreferenceJulian BA, Laskow DA, Dubovsky J, Dubovsky EV, Curtis JJ, Quarles LD. Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 1991; 325: 544 – 550.en_US
dc.identifier.citedreferenceKasiske BL, Chakkera HA, Roel J. Explained and unexplained ischemic heart disease risk after renal transplantation. J Am Soc Nephrol 2000; 11: 1735 – 1743.en_US
dc.identifier.citedreferenceSinclair NR. Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. The Canadian Multicentre Transplant Study Group. CMAJ 1992; 147: 645 – 657.en_US
dc.identifier.citedreferenceHricik DE, O’Toole MA, Schulak JA, Herson J. Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: A meta-analysis. J Am Soc Nephrol 1993; 4: 1300 – 1305.en_US
dc.identifier.citedreferenceAlmawi WY, Hess DA, Assi JW, Chudzik DM, Rieder MJ. Pretreatment with glucocorticoids enhances T-cell effector function: Possible implication for immune rebound accompanying glucocorticoid withdrawal. Cell Transplant 1999; 8: 637 – 647.en_US
dc.identifier.citedreferenceKasiske BL, Chakkera HA, Louis TA, Ma JZ. A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol 2000; 11: 1910 – 1917.en_US
dc.identifier.citedreferenceVincenti F, Monaco A, Grinyo J, Kinkhabwala M, Roza A. Multicenter randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporine microemulsion and mycophenolate mofetil. Am J Transplant 2003; 3: 306 – 311.en_US
dc.identifier.citedreferenceMatas AJ, Kandaswamy R, Gillingham KJ et al. Prednisone-free maintenance immunosuppression-a 5-year experience. Am J Transplant 2005; 5: 2473 – 2478.en_US
dc.identifier.citedreferenceKumar MS, Heifets M, Moritz MJ et al. Safety and efficacy of steroid withdrawal two days after kidney transplantation: Analysis of results at three years. Transplantation 2006; 81: 832 – 839.en_US
dc.identifier.citedreferenceRostaing L, Cantarovich D, Mourad G et al. Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation. Transplantation 2005; 79: 807 – 814.en_US
dc.identifier.citedreferenceVincenti F, Schena FP, Paraskevas S, Hauser IA, Walker RG, Grinyo J. A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients. Am J Transplant 2008; 8: 307 – 316.en_US
dc.identifier.citedreferenceHricik DE, Augustine JJ, Knauss TCC et al. Long-term graft outcomes after steroid withdrawal in African American kidney transplant recipients receiving sirolimus and tacrolimus. Transplantation 2007; 83: 277 – 281.en_US
dc.identifier.citedreferenceWoodle ES, Alloway RR, Buell JF et al. Multivariate analysis of risk factors for acute rejection in early corticosteroid cessation regimens under modern immunosuppression. Am J Transplant 2005; 5: 2740 – 2744.en_US
dc.identifier.citedreferenceVitko S, Klinger M, Salmela K et al. Two corticosteroid-free regimens-tacrolimus monotherapy after basiliximab administration and tacrolimus/mycophenolate mofetil-in comparison with a standard triple regimen in renal transplantation: Results of the Atlas study. Transplantation 2005; 80: 1734 – 1741.en_US
dc.identifier.citedreferenceKandaswamy R, Melancon JK, Dunn T et al. A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients—an interim analysis. Am J Transplant 2005; 5: 1529 – 1536.en_US
dc.identifier.citedreferenceKaufman DB, Leventhal JR, Axelrod D, Gallon LG, Parker MA, Stuart FP. Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: Comparison with basiliximab induction—long-term results. Am J Transplant 2005; 5: 2539 – 2548.en_US
dc.identifier.citedreferenceBorrows R, Chan K, Loucaidou M et al. Five years of steroid sparing in renal transplantation with tacrolimus and mycophenolate mofetil. Transplantation 2006; 81: 125 – 128.en_US
dc.identifier.citedreferenceHumar A, Gillingham K, Kandaswamy R, Payne W, Matas A. Steroid avoidance regimens: A comparison of outcomes with maintenance steroids versus continued steroid avoidance in recipients having an acute rejection episode. Am J Transplant 2007; 7: 1948 – 1953.en_US
dc.identifier.citedreferenceAnil Kumar MS, Heifets M, Fyfe B et al. Comparison of steroid avoidance in tacrolimus/mycophenolate mofetil and tacrolimus/sirolimus combination in kidney transplantation monitored by surveillance biopsy. Transplantation 2005; 80: 807 – 814.en_US
dc.identifier.citedreferenceCopeland KT, Checkoway H, McMichael AJ, Holbrook RH. Bias due to misclassification in the estimation of relative risk. Am J Epidemiol 1977; 105: 488 – 495.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1600-6143.2008.02442.x.pdf
Size:
359.8KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.